Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix.
about
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsComparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy resultsPrevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL.Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopyEvaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening.Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.Hybrid Capture 2 and cobas human papillomavirus assays perform similarly on SurePath samples from women with abnormalities.Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening.Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2.Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.High-risk HPV platforms and test of cure: should specific HPV platforms more suited to screening in a 'test of cure' scenario be recommended?cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens.
P2860
Q24198236-E10C3CB4-7EBB-4F29-86D6-E52A97F510C8Q34298145-DE1F334C-937E-4E85-9577-5AFD87EBFAACQ34637954-0E4F0922-9A09-4318-93A0-67CCEE59A9B3Q35729645-01089966-12FE-45C9-8A4C-F6F77AAEE73AQ36118559-1B0149AD-7AFB-490D-8D8B-227E0A5AA5C5Q37264293-6672BFC2-8DDF-4ABD-A67F-BEEEC764A748Q37289143-33CF34AA-A3EB-484F-B0B8-7454E9C3E7EBQ37496183-564B6929-F212-46AD-B6DB-C64A9B144BA5Q39909954-D058C139-04BC-455C-B21D-99FBA81AFA19Q40043990-6DFA1978-0C9C-4319-BA1A-C8D371676B89Q40943325-D356A116-C62A-495E-99B7-005D66A536DDQ41284477-B604E8FA-8AFF-447F-9E46-8C61AA85F46BQ41654359-C64D2EDC-A0D3-448F-BE8F-2D572650F999Q42251001-9640BED3-5227-4646-BC61-A98BD1B09FF8
P2860
Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Human papillomavirus (HPV) DNA ...... lesions of the uterine cervix.
@ast
Human papillomavirus (HPV) DNA ...... lesions of the uterine cervix.
@en
type
label
Human papillomavirus (HPV) DNA ...... lesions of the uterine cervix.
@ast
Human papillomavirus (HPV) DNA ...... lesions of the uterine cervix.
@en
prefLabel
Human papillomavirus (HPV) DNA ...... lesions of the uterine cervix.
@ast
Human papillomavirus (HPV) DNA ...... lesions of the uterine cervix.
@en
P2093
P2860
P356
P1476
Human papillomavirus (HPV) DNA ...... lesions of the uterine cervix.
@en
P2093
Alex Ferenczy
Bertrand Michon
Diane Provencher
François Coutlée
Marie-Hélène Mayrand
Marie-Josée Dupuis
Patrick Petignat
Philippe Gauthier
Philippe Sauthier
Pierre Drouin
P2860
P304
P356
10.1128/JCM.06656-11
P407
P577
2012-02-01T00:00:00Z